Lbp Am Sa Sells 3,198 Shares of The Clorox Company (NYSE:CLX)

LBP AM SA reduced its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 3.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 80,924 shares of the company's stock after selling 3,198 shares during the quarter. LBP AM SA owned about 0.07% of Clorox worth $11,916,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of CLX. Redwood Park Advisors LLC bought a new stake in Clorox during the 4th quarter worth approximately $26,000. Millstone Evans Group LLC bought a new stake in Clorox during the fourth quarter worth $31,000. Wood Tarver Financial Group LLC purchased a new stake in Clorox in the 4th quarter valued at $31,000. GKV Capital Management Co. Inc. purchased a new position in Clorox during the 4th quarter worth $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of Clorox in the fourth quarter valued at about $33,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Price Performance

CLX traded down $1.29 during trading on Friday, reaching $126.55. 1,376,644 shares of the company were exchanged, compared to its average volume of 1,409,949. The Clorox Company has a 12-month low of $117.35 and a 12-month high of $171.37. The company's 50-day moving average is $128.52 and its two-hundred day moving average is $142.83. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The company has a market cap of $15.60 billion, a price-to-earnings ratio of 22.72, a P/E/G ratio of 3.10 and a beta of 0.51.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a return on equity of 324.23% and a net margin of 9.89%. The business had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter last year, the business posted $1.71 EPS. The company's quarterly revenue was down 8.0% on a year-over-year basis. Research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

CLX has been the topic of several recent analyst reports. JPMorgan Chase & Co. dropped their target price on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 6th. Wells Fargo & Company decreased their target price on Clorox from $142.00 to $135.00 and set an "equal weight" rating for the company in a research report on Wednesday. Jefferies Financial Group cut their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Evercore ISI set a $140.00 price objective on shares of Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Finally, Morgan Stanley dropped their target price on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Clorox has an average rating of "Hold" and a consensus price target of $148.92.

Insider Activity

In other news, Director Pierre R. Breber bought 4,000 shares of the business's stock in a transaction dated Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the acquisition, the director owned 4,000 shares of the company's stock, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.57% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.